Trial Profile
A Prospective, Randomized, Double-Blind Comparison of LY900014 and Fiasp®, Both in Combination with Basal Insulin in Adults with Type 1 Diabetes, PRONTO-Compare
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 19 Dec 2018
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PRONTO-Compare
- Sponsors Eli Lilly and Company (India) Pvt. Ltd
- 15 Nov 2018 This trial has been Discontinued in Austria, according to European Clinical Trials Database.
- 08 Nov 2018 New trial record